Physician profile
David S Lu
NPI 1255515417
$3,112.67
in general payments reported to CMS, 2019-2025
28 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $262 · 2021: $732 · 2022: $512 · 2023: $234 · 2024: $533 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.09 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $489.76 | 2019-2024 | Tymlos |
| Abbvie INC. | $409.42 | 2019-2022 | |
| Novo Nordisk INC | $269.26 | 2019-2024 | Wegovy |
| Evofem Biosciences, INC. | $197.54 | 2020-2025 | Phexxi, Solosec, Phexx |
| Millicent US INC | $179.33 | 2021-2025 | Femring, Intrarosa, Femlyv |
| Roche Diagnostics Corporation | $158.54 | 2019-2020 | |
| Abbott Laboratories | $149.39 | 2024 | Mitraclip |
| Pfizer INC. | $140.00 | 2021-2023 | |
| Therapeuticsmd, INC. | $122.91 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $121.68 | 2019 | |
| Exact Sciences Corporation | $110.94 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $93.56 | 2024 | Zepbound |
| Aspira Women'S Health INC | $76.28 | 2022 | |
| Mayne Pharma Commercial LLC | $71.31 | 2021-2024 | |
| Myovant Sciences INC. | $68.57 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $60.93 | 2021 | |
| Sumitomo Pharma America, INC. | $57.03 | 2023-2024 | Myfembree |
| Ascend Therapeutics US, LLC | $54.85 | 2021-2024 | |
| Heron Therapeutics, INC. | $48.97 | 2024 | Zynrelef |
| Avion Pharmaceuticals | $44.29 | 2021-2023 | Balcoltra |
| Exeltis, USA INC. | $38.48 | 2022-2024 | Slynd |
| Ethicon US, LLC | $34.98 | 2019-2021 | |
| Allergan, INC. | $34.24 | 2019 | |
| Alnylam Pharmaceuticals INC. | $21.28 | 2022 | |
| Sage Therapeutics, LLC | $19.78 | 2025 | Zurzuvae |
| Kowa Pharmaceuticals America, INC. | $14.05 | 2023 | Livalo, Seglentis |
| Mission Pharmacal Company | $13.85 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.